Kite Pharma vs Lyell Immunopharma
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer
4013 employees · est. 2009 · Santa Monica, United States
Lyell Immunopharma
At Lyell, we are advancing next-generation CAR T-cell product candidates for patients with cancer
229 employees · est. 2018 · South San Francisco, United...
Kite Pharma is the older company (2009 vs 2018); Kite Pharma is the larger of the two.
Side-by-Side Comparison
| Metric | Kite Pharma | Lyell Immunopharma |
|---|---|---|
| Founded | ||
| Founded | 2009 older | 2018 |
| Headquarters | ||
| Headquarters | Santa Monica, United States | South San Francisco, United States |
| Employees | ||
| Employees | 4013 larger | 229 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Acquired | Not tracked yet |
| Total Funding | ||
| Total Funding | $12.56B | $968.00M |
| Funding Rounds | ||
| Funding Rounds | 8 | 6 |
| Services | ||
| Services | Cell Therapy Development, Manufacturing of CAR T-cell Therapies, Clinical Trials and Research, Patient Support and Resources, External Research Programs | Development of Next-Generation CAR T-Cell Product Candidates, Cancer Cell Killing Capabilities, Clinical-Stage Research and Development, Advanced Manufacturing and Supply Chain Management, Cancer Target Identification |
| Target Customers | ||
| Target Customers | Cancer Patients, Healthcare Providers, Research Institutions, Biopharmaceutical Investors, Oncology Care Centers | Cancer Patients, Healthcare Providers, Medical Researchers, Oncologists, Healthcare Institutions |
| Taxonomy | ||
| Taxonomy | Cell TherapyCancer ImmunotherapyHematologic MalignanciesEngineered T Cell TherapyAutologous Cell TherapyImmune-Based Targeted Therapies +7 | CAR T-cell TherapiesCancer TreatmentCell TherapyClinical Stage BiotechnologyT-cell BiologyImmunotherapy +9 |
| Website | ||
| Website | kitepharma.com | lyell.com |
About Kite Pharma
Kite Pharma, based in Santa Monica, United States, specializes in cell therapy aimed at treating and curing cancer. The company serves cancer patients, healthcare providers, research institutions, biopharmaceutical investors, and oncology care centers. Founded in 2009, Kite Pharma offers services s...
About Lyell Immunopharma
Lyell Immunopharma, a United States-based biotechnology firm, is pioneering the development of next-generation CAR T-cell therapies aimed at cancer treatment. Founded in 2018 by cell therapy pioneers, the company leverages cutting-edge technology to enhance T cells with characteristics of resistance...
Also comparing in this category
Comparing more than these two?
Get Kite Pharma, Lyell Immunopharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Kite Pharma compare?
A PDF of Kite Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Kite Pharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Kite Pharma on 10 Jun 2026, and Lyell Immunopharma on 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
